ICBI, Inc.

Home
ICBI, Inc.

ICBII is a development-stage biotechnology company.

Its biologics specifically target pathologic proteins in the central nervous system, offering clinical potential for early diagnosis, monitoring and treatment of brain diseases. ICBII has developed the breakthrough SMART Molecule Technology Platform (SM), capable of delivering therapeutic drugs across the blood-brain barrier (BBB) into the central nervous system (CNS) to diagnose and alter the course of brain diseases.

06/12/2017

New Press Release

LA JOLLA, Calif., Dec. 5, 2017 /PRNewswire/ -- Innovative California Biosciences International, Inc., ("ICBII"),...

Address

Website

http://icbii.com/

Alerts

Be the first to know and let us send you an email when ICBI, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to ICBI, Inc.:

Shortcuts